CATO SMS
LIVE

Serial Number

88981012

Owner

Clinical Services Corporate Operations, Inc.

Attorney

Laura M. Franco

First Use Date

Sep 1, 2020

Filing Date

Jan 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CATO SMS Trademark

Serial Number: 88981012 • Registration: 6391003

CATO SMS is a trademark filed by Clinical Services Corporate Operations, Inc. on January 22, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clinical Services Corporate Operations, Inc. (12 trademarks)

Waltham, MA 02452

Entity Type: 03

Trademark Details

Filing Date

January 22, 2020

Registration Date

June 15, 2021

First Use Anywhere

September 1, 2020

First Use in Commerce

September 1, 2020

Published for Opposition

June 30, 2020

Goods & Services

providing statistical information and analysis, data processing, project planning and cost management services for preclinical and clinical trials in the fields of pharmaceuticals, biotechnology, medical devices and diagnostics; designing laboratory research, namely, managing and monitoring preclinical and clinical trials; data management, namely, abstraction and collection of medical data from clinical tests for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries

data management, namely, collection of patient-generated health data for scientific research purposes; Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; providing a web-based portal for study sponsors and contract research organizations (CROs) to build programs, enroll members, automate actions, and visualize/analyze data in connection with clinical studies; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production

training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support

development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance in drug, biologic, cosmetic and medical device development

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 15, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 12, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 11, 2021 CNPR
EXAMINER'S AMENDMENT ENTERED
Apr 12, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 12, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 12, 2021 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Apr 12, 2021 SNEA
STATEMENT OF USE PROCESSING COMPLETE
Mar 17, 2021 SUPC
DIVISIONAL PROCESSING COMPLETE
Mar 17, 2021 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 15, 2021 AITU
USE AMENDMENT FILED
Feb 24, 2021 IUAF
DIVISIONAL REQUEST RECEIVED
Feb 24, 2021 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Feb 24, 2021 ERTD
TEAS STATEMENT OF USE RECEIVED
Feb 24, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 25, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 26, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 26, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2020 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 21, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 21, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 21, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 21, 2020 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2020 NWOS
NEW APPLICATION ENTERED
Jan 25, 2020 NWAP